Chester County News and Community Website
RADNOR, PA — NRx Pharmaceuticals (Nasdaq: NRXP) announced this week that it has completed an analysis to identify clinical evidence that indicates a substantial improvement after treatment with ZYESAMI® (aviptadil) …
Read More RADNOR, PA — NRx Pharmaceuticals (NRx) (NASDAQ: NRXP) recently provided a safety update on ZYESAMI™ (aviptadil) which is being tested in the ACTIV-3b Critical Care Phase 3 study sponsored by …
Read More RADNOR, PA — NRx Pharmaceuticals (Nasdaq: NRXP) recently announced top line data demonstrating improved outcomes at one year in highly comorbid patients with COVID-19 who were treated with ZYESAMI™.
Read More
WILMINGTON, DE — Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) recently announced new preliminary clinical data from the 6mg cohort of its ongoing Phase 2 ACCURACY trial of AL101 for the treatment …
Read More RADNOR, PA — NRx Pharmaceuticals (NRx) (NASDAQ: NRXP) recently provided a safety update on ZYESAMI™ (aviptadil) which is being tested in the ACTIV-3 Critical Care Phase 3 study sponsored by the National …
Read More
DOYLESTOWN, PA — assisTek, a boutique eSource company known for providing customized solutions to support clinical trial teams for two and a half decades, has collaborated with a California health technology company to …
Read More
RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and Quantum Leap Healthcare Collaborative™ have begun treating patients with inhaled ZYESAMIÔ (Aviptadil), in the I-SPY COVID Trial (NCT04488081), a phase 2 adaptive platform …
Read More DOYLESTOWN, PA — assisTek has announced the release of the next generation of its electronic clinical outcome assessment (eCOA) platform.
Read More
BERWYN, PA — Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX), announced that the Investigational New Drug (IND) Application enabling studies for Envelta™ being performed under a Cooperative Research and Development Agreement (CRADA) …
Read More DOYLESTOWN, PA — assisTek, a leader in innovative eClinical technology and eSource solutions for clinical research, announced its strategic partnership with Crown Tech, a leading technology, consulting, and software development …
Read More